FOXM1 modulates cisplatin sensitivity by regulating EXO1 in ovarian cancer.
Cisplatin is commonly used in ovarian cancer chemotherapy, however, chemoresistance to cisplatin remains a great clinical challenge. Oncogenic transcriptional factor FOXM1 has been reported to be overexpressed in ovarian cancer. In this study, we aimed to investigate the potential role of FOXM1 in o...
Main Authors: | Jinhua Zhou, Yunfei Wang, You Wang, Xia Yin, Yifeng He, Lilan Chen, Wenwen Wang, Ting Liu, Wen Di |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4019642?pdf=render |
Similar Items
-
Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
by: Yujie Zhao, et al.
Published: (2021-07-01) -
FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma
by: Yingru Zhi, et al.
Published: (2019-06-01) -
FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
by: Zhenwang Zhang, et al.
Published: (2023-05-01) -
FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
by: Ming-ju Huang, et al.
Published: (2018-02-01) -
Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin
by: Qia Xu, et al.
Published: (2022-06-01)